Shares of Tyson Foods Inc. (NYSE: TSN) were down on Wednesday. The stock has dropped 6% over the past three months. The company is scheduled to report its second quarter 2023 earnings results on Monday, May 8, before market open. Here’s what to expect from the earnings report:
Revenue
Analysts are projecting revenue of $13.6 billion for Tyson in Q2 2023, which would represent an increase of nearly 4% from the same period a year ago. In the first quarter of 2023, sales increased 2.5% year-over-year to $13.2 billion.
Earnings
The consensus estimate is for EPS of $0.80 in Q2 2023, which is down from EPS of $2.29 reported in the year-ago quarter. In Q1 2023, adjusted EPS was $0.85, down 70% year-over-year.
Points to note
In the first quarter of 2023, Tyson reported sales growth helped by strength in the Chicken, Prepared Foods, and International segments. The company is optimistic on the potential of its Prepared Foods business and the strength of its retail brands in this segment. Prepared Foods has benefited from volume growth and pricing actions and this momentum is likely to continue in Q2. The Chicken segment also benefited from higher volume and pricing actions during the first quarter.
Tyson’s results in Q1 were impacted by lower demand in beef and pork. In addition, the company continues to feel the pressure of higher costs which has hurt its margins and taken a toll on its profitability. This is likely to pose a challenge in the second quarter as well.
In an effort to tackle rising costs, Tyson decided to shut down two of its poultry farms in the US and lay off nearly 1,700 workers. The company also announced that it was going to cut 10% of corporate jobs and 15% of its senior leadership team. These are significant areas to keep an eye on in the Q2 report.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
What to expect when J.M. Smucker (SJM) reports Q2 2025 earnings results
Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Friday. The stock has dropped 6% over the past three months. The branded foods company is slated to report
Earnings Summary: Highlights of BJ’s Wholesale Club’s Q3 2024 results
Department store chain BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has reported financial results for the third quarter of 2024, reporting a 3% increase in net sales. Adjusted earnings, on a